Key result
Fibrin and fibrinogen drive atherosclerosis progression through thrombin binding and mitogenic degradation products.
Answers are grounded in this paper and cite their sources.
Research reveals that fibrin and plasma proteins influence arterial wall integrity, impacting atherosclerosis.
Virtually all plasma proteins, including fibrinogen, low density lipoprotein and lipoprotein(a), are present in normal arterial intima and in atherosclerotic lesions, and their concentrations are related to plasma concentrations. Fibrin is also a significant component of many lesions, particularly early proliferative (gelatinous) lesions, where it may be muscle cells migrate and proliferate, bind thrombin, and are a source of fibrin degradation products (FDPs), which are mitogenic. Very recent studies suggest that free a-thrombin may be present in lesions despite an apparent excess of antithrombin III, so this may promote fibrin formation within the lesion. Furthermore, fibrinolysis and FDP generation may be mediated by catheptic enzymes in addition to plasmin.
No takes yet. Share an insight, caveat, or question.
E. B. Smith (1995) conducted a review in Atherosclerosis. Fibrinogen and fibrin was evaluated. Fibrin and fibrinogen are significant components of atherosclerotic lesions that may promote disease progression via thrombin binding and mitogenic degradation products.
Synapse has enriched 10 related papers. Consider them for comparative context: